author-photo

Zsuzsanna Márk

6

Papers

630

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for Small-Cell Lung Cancer: Primary and Correlative Biomarker Analyses

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (33)
TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study

2014 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (195)
A randomized phase II study of paclitaxel (P) and carboplatin (C) {+/-} bevacizumab (B) {+/-} dulanermin (D) in non-small cell lung cancer (NSCLC).

2010 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-α blockade in severe persistent asthma

2009 American Journal of Respiratory and Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (392)